Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5

  • Gamez-Garcia, Andrés|||0000-0003-4927-3678
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Bueno-Costa, Alberto|||0000-0001-8700-2540
  • Alari Pahissa, Elisenda|||0000-0001-7424-5383
  • Marazuela-Duque, Anna
  • Thackray, Joshua K.|||0000-0003-2828-452X
  • Ray, Chandni
  • Berenguer Balaguer, Clara
  • Kumari, Poonam
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Braun, Thomas|||0000-0002-6165-4804
  • Ianni, Alessandro|||0000-0001-7398-589X
  • Tischfield, Jay A.|||0000-0003-3217-8287
  • Serrano, Lourdes
  • Esteller, M.|||0000-0003-4490-6093
  • Sardina, José Luis|||0000-0002-8493-3937
  • De La Torre, Carolina
  • Sigvardsson, Mikael|||0000-0001-8527-7276
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Vaquero, Alejandro|||0000-0002-8735-4156
B lymphopoiesis is orchestrated by lineage-specific transcription factors. In B cell progenitors, lineage commitment is mediated by Pax5, which is commonly mutated in B cell acute lymphoblastic leukemia. Despite its essential role in immunity, the mechanisms regulating Pax5 function remain largely unknown. Here, we found that the NAD-dependent enzyme SIRT7 coordinates B cell development through deacetylation of Pax5 at K198, which promotes Pax5 protein stability and transcriptional activity. Neither Pax5 deacetylated nor acetylated mimics rescued B cell differentiation in Pax5 pro-B cells, suggesting that B cell development requires Pax5 dynamic deacetylation. The Pax5 deacetylation mimic restored lineage commitment in Pax5 pro-B cells and B cell differentiation in Sirt7 pro-B cells, suggesting the uncoupling of differentiation from lineage commitment. The SIRT7-Pax5 interplay was conserved in B cell acute lymphoblastic leukemia, where SIRT7 expression correlated with good prognosis. Our findings reveal a crucial mechanism for B lymphopoiesis and highlight the relevance of sirtuins in immune function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia

  • Launay, Nathalie|||0000-0002-7498-217X
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Verdura, Edgard|||0000-0003-3856-2060
  • Fernández-Eulate, Gorka|||0000-0003-1112-7464
  • Ondaro, Jon|||0000-0002-2879-9497
  • Iruzubieta, Pablo
  • Marsal, Maria|||0000-0001-9678-8717
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Fourcade, Stéphane|||0000-0002-8031-5007
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Zulaica, Miren
  • Sistiaga, Andone|||0000-0003-2511-0911
  • Labayru, Garazi
  • Loza-Alvarez, Pablo|||0000-0002-3129-1213
  • Vaquero, Alejandro|||0000-0002-8735-4156
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Pujol, Aurora|||0000-0002-9606-0600
Senescence, marked by permanent cell cycle arrest may contribute to the decline in regenerative potential and neuronal function, thereby promoting neurodegenerative disorders. In this study, we employed whole exome sequencing to identify a previously unreported biallelic missense variant in SVBP (p.Leu49Pro) in six patients from three unrelated families. These affected individuals present with a complex hereditary spastic paraplegia (HSP), peripheral neuropathy, verbal apraxia, and intellectual disability, exhibiting a milder phenotype compared to patients with nonsense SVBP mutations described previously. Consistent with SVBP's primary role as a chaperone necessary for VASH-mediated tubulin detyrosination, both patient fibroblasts with the p.Leu49Pro mutation, and HeLa cells harboring an SVBP knockdown exhibit microtubule dynamic instability and alterations in pericentriolar material (PCM) component trafficking and centrosome cohesion. In patient fibroblasts, structural abnormalities in the centrosome trigger mitotic errors and cellular senescence. Notably, premature senescence characterized by elevated levels of p16INK4, was also observed in patient peripheral blood mononuclear cells (PBMCs). Taken together, our findings underscore the critical role of SVBP in the development and maintenance of the central nervous system, providing novel insights associating cytokinesis failure with cortical motor neuron disease and intellectual disability.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin

  • González Miranda, Jessica|||0000-0001-7732-1564
  • Bosch-Presegué, Laia|||0000-0001-8025-2416
  • Marazuela Duque, Anna|||0000-0001-6787-8668
  • Guitart-Solanes, Anna
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Fernandez, Agustín F.
  • Brown, Jeremy P.
  • Ausió, Juan
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Singh, Prim B.
  • Fraga, Mario|||0000-0001-8450-2603
  • Vaquero, Alejandro|||0000-0002-8735-4156
Pericentric heterochromatin (PCH) plays an essential role in the maintenance of genome integrity and alterations in PCH have been linked to cancer and aging. HP1 α, β, and γ, are hallmarks of constitutive heterochromatin that are thought to promote PCH structure through binding to heterochromatin-specific histone modifications and interaction with a wide range of factors. Among the less understood components of PCH is the histone H2A variant H2A.Z, whose role in the organization and maintenance of PCH is poorly defined. Here we show that there is a complex interplay between H2A.Z and HP1 isoforms in PCH. While the loss of HP1α results in the accumulation of H2A.Z.1 in PCH, which is associated with a significant decrease in its mobile fraction, H2A.Z.1 binds preferentially to HP1β in these regions. Of note, H2A.Z.1 downregulation results in increased heterochromatinization and instability of PCH, reflected by accumulation of the major epigenetic hallmarks of heterochromatin in these regions and increased frequency of chromosome aberrations related to centromeric/pericentromeric defects. Our studies support a role for H2A.Z in genome stability and unveil a key role of H2A.Z in the regulation of heterochromatin-specific epigenetic modifications through a complex interplay with the HP1 isoforms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

SIRT7, a novel molecular target for personalized cancer treatment?

  • Ianni, Alessandro|||0000-0001-7398-589X
  • Kumari, Poonam
  • Tarighi, Shahriar|||0000-0003-3807-9212
  • Braun, Thomas|||0000-0002-6165-4804
  • Vaquero, Alejandro|||0000-0002-8735-4156
The Sirtuin family of NAD-dependent enzymes assumes a pivotal role in orchestrating adaptive responses to environmental fluctuations and stress stimuli, operating at both genomic and metabolic levels. Within this family, SIRT7 emerges as a versatile player in tumorigenesis, displaying both pro-tumorigenic and tumor-suppressive functions in a context-dependent manner. While other sirtuins, such as SIRT1 and SIRT6, exhibit a similar dual role in cancer, SIRT7 stands out due to distinctive attributes that sharply distinguish it from other family members. Among these are a unique key role in regulation of nucleolar functions, a close functional relationship with RNA metabolism and processing -exceptional among sirtuins- and a complex multienzymatic nature, which provides a diverse range of molecular targets. This review offers a comprehensive overview of the current understanding of the role of SIRT7 in various malignancies, placing particular emphasis on the intricate molecular mechanisms employed by SIRT7 to either stimulate or counteract tumorigenesis. Additionally, it delves into the unique features of SIRT7, discussing their potential and specific implications in tumor initiation and progression, underscoring the promising avenue of targeting SIRT7 for the development of innovative anti-cancer therapies.